Clin2
NCT06742164Possibly a fitNot yet recruiting

Ivabradine for heart rate control in sepsis

Heart Rhythm Disorder

Treatments studied

Part of Heart & circulation clinical trials.

This study tests whether a drug called ivabradine can safely lower a fast heart rate in people with sepsis (a severe infection that affects the whole body). It aims to see if controlling heart rate helps improve recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
76 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have a confirmed or suspected infection.
  • You have sepsis or septic shock (severe infection causing organ problems or low blood pressure).
  • Your heart beats at least 95 times per minute while at rest.
  • You have a regular heart rhythm (not atrial fibrillation or other irregular rhythms).
  • You are not currently taking other drugs that slow the heart rate.
  • You do not have severe kidney or liver failure, and you are not pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05882708Recruiting· Phase 4
Ivabradine to slow heart rate in sepsis ICU patients

This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.

Guangzhou, Guangdong
NCT04844801Recruiting
Prevent fast heart rhythms during sepsis shock with rate control drugs

This trial tests whether a heart-rate–controlling medication can better manage a new fast heart rhythm that happens during sepsis shock. It may help reduce heart strain and improve safety compared with standard care.

Paris
NCT07714746Recruiting· Phase 3
Ivabradine for treating cardiogenic shock after heart attack

This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.

Karachi
NCT07797946Not yet recruiting
Ivabradine before sinus surgery for steady heart rate

This trial tests whether giving a drug called ivabradine before sinus surgery helps keep your heart rate steady during the procedure. It may reduce risks during surgery for people with a normal resting heart rate.

NCT07717710Recruiting· Early Phase 1
Heart rate medication for healthy adults during exercise

This study tests a pill called ivabradine that lowers heart rate, to see how it affects healthy adults when they exercise. Participation requires two supervised exercise sessions.

Vancouver, British Columbia
NCT06853574Not yet recruiting
Heart and blood vessel function in sepsis

This study looks at how well the heart and blood vessels work together in people with sepsis or septic shock. It may help doctors understand heart function better during serious infections, which could lead to improved care.

Celje

Hear when a new Heart Rhythm Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.